Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chase Pharmaceuticals
Biotech
Chase gets cash for pivotal trials in depression, Parkinson's
Armed with $20 million, the biotech plans to start phase 3 clinical trials of candidates based on an old Boehringer Ingelheim drug.
Nick Paul Taylor
Oct 20, 2021 8:55am
Chutes & Ladders—Allergan vet to replace Kaye as Sarepta’s CEO
Jun 30, 2017 7:33am
Sarepta hires ex-Allergan leader with M&A history as CEO
Jun 29, 2017 5:25am
Allergan chases high-dose, low side effects Alzheimer’s combo in biotech buy
Nov 23, 2016 3:50am
